RxSight (RXST) Operating Leases (2020 - 2026)

RxSight (RXST) has 7 years of Operating Leases data on file, last reported at $9.3 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases fell 15.15% year-over-year to $9.3 million; the trailing twelve-month figure through Mar 2026 stood at $9.3 million (down 15.15% YoY), and the FY2025 full-year result was $9.9 million, down 12.75% from the prior year.
• Operating Leases for Q1 2026 stood at $9.3 million, down from $9.9 million in the prior quarter.
• Across five years, Operating Leases topped out at $11.3 million in Q4 2024 and bottomed at $908000.0 in Q1 2024.
• The 5-year median for Operating Leases is $3.9 million (2022), against an average of $6.2 million.
• The widest annual swing landed in 2024, when Operating Leases tumbled 61.16%; it then soared 1110.02% in 2025.
• A 5-year view of Operating Leases shows it stood at $2.9 million in 2022, then sank by 57.6% to $1.2 million in 2023, then surged by 834.93% to $11.3 million in 2024, then decreased by 12.75% to $9.9 million in 2025, then retreated by 5.63% to $9.3 million in 2026.
• The last three Operating Leases figures came in at $9.3 million (Q1 2026), $9.9 million (Q4 2025), and $10.3 million (Q3 2025), per Business Quant data.

Peer Comparison